1-[2-(2,4-Dimetilfenilsulfanil)fenil]piperazina como compuesto con recaptación de serotonina combinada con actividad 5-HT3 y 5-HT1A para el tratamiento del deterioro cognitivo
1-[2-(2,4-Dimetilfenilsulfanil)fenil]piperazina y sus sales farmacéuticamente aceptables, cuyo compuesto es cristalino. 1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on SERT, 5-HT 3 and 5-HT 1A and may as such be useful for the treatment of cognitive impairment, especi...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | RINGGAARD, LONE MUNCH MOERK, ARNE FALDT, ANDRE HOLM, RENE ROCK, MICHAEL HAROLD BRODERSEN, JOERGEN BANG-ANDERSEN, BENNY JOERGENSEN, MORTEN MEALY, MICHAEL J MOORE, NICHOLAS LOPEZ DE DIEGO, HEIDI STENSBOEL, TINE BRYAN |
| description | 1-[2-(2,4-Dimetilfenilsulfanil)fenil]piperazina y sus sales farmacéuticamente aceptables, cuyo compuesto es cristalino.
1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on SERT, 5-HT 3 and 5-HT 1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2379200TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2379200TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2379200TT33</originalsourceid><addsrcrecordid>eNqNjcFqAjEQhvfSg1jfYbxZMKC7SvEo1eLdvYnImMyWgWwSklnBPlWhj9AXa3bxAbzMNz98M_-o-FmqU6lm5XyldtySsG3IsU2dbTDzbUjnwIEifrND0L71_QgdJek3B5E0BkHNf78ODEGi6MW7h33NNDiIqIVvbNDAWh3qCu4Dl1sIGBHIgkQUbJlc_mxyNiQU2ce-58txvvavxUuDNtHkwXEx_dzXHwdFwV8oBdTkSC77Y1m9b8rFoq6r6hnnHzlTWjs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>1-[2-(2,4-Dimetilfenilsulfanil)fenil]piperazina como compuesto con recaptación de serotonina combinada con actividad 5-HT3 y 5-HT1A para el tratamiento del deterioro cognitivo</title><source>esp@cenet</source><creator>RINGGAARD, LONE MUNCH ; MOERK, ARNE ; FALDT, ANDRE ; HOLM, RENE ; ROCK, MICHAEL HAROLD ; BRODERSEN, JOERGEN ; BANG-ANDERSEN, BENNY ; JOERGENSEN, MORTEN ; MEALY, MICHAEL J ; MOORE, NICHOLAS ; LOPEZ DE DIEGO, HEIDI ; STENSBOEL, TINE BRYAN</creator><creatorcontrib>RINGGAARD, LONE MUNCH ; MOERK, ARNE ; FALDT, ANDRE ; HOLM, RENE ; ROCK, MICHAEL HAROLD ; BRODERSEN, JOERGEN ; BANG-ANDERSEN, BENNY ; JOERGENSEN, MORTEN ; MEALY, MICHAEL J ; MOORE, NICHOLAS ; LOPEZ DE DIEGO, HEIDI ; STENSBOEL, TINE BRYAN</creatorcontrib><description>1-[2-(2,4-Dimetilfenilsulfanil)fenil]piperazina y sus sales farmacéuticamente aceptables, cuyo compuesto es cristalino.
1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on SERT, 5-HT 3 and 5-HT 1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.</description><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120423&DB=EPODOC&CC=ES&NR=2379200T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120423&DB=EPODOC&CC=ES&NR=2379200T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RINGGAARD, LONE MUNCH</creatorcontrib><creatorcontrib>MOERK, ARNE</creatorcontrib><creatorcontrib>FALDT, ANDRE</creatorcontrib><creatorcontrib>HOLM, RENE</creatorcontrib><creatorcontrib>ROCK, MICHAEL HAROLD</creatorcontrib><creatorcontrib>BRODERSEN, JOERGEN</creatorcontrib><creatorcontrib>BANG-ANDERSEN, BENNY</creatorcontrib><creatorcontrib>JOERGENSEN, MORTEN</creatorcontrib><creatorcontrib>MEALY, MICHAEL J</creatorcontrib><creatorcontrib>MOORE, NICHOLAS</creatorcontrib><creatorcontrib>LOPEZ DE DIEGO, HEIDI</creatorcontrib><creatorcontrib>STENSBOEL, TINE BRYAN</creatorcontrib><title>1-[2-(2,4-Dimetilfenilsulfanil)fenil]piperazina como compuesto con recaptación de serotonina combinada con actividad 5-HT3 y 5-HT1A para el tratamiento del deterioro cognitivo</title><description>1-[2-(2,4-Dimetilfenilsulfanil)fenil]piperazina y sus sales farmacéuticamente aceptables, cuyo compuesto es cristalino.
1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on SERT, 5-HT 3 and 5-HT 1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjcFqAjEQhvfSg1jfYbxZMKC7SvEo1eLdvYnImMyWgWwSklnBPlWhj9AXa3bxAbzMNz98M_-o-FmqU6lm5XyldtySsG3IsU2dbTDzbUjnwIEifrND0L71_QgdJek3B5E0BkHNf78ODEGi6MW7h33NNDiIqIVvbNDAWh3qCu4Dl1sIGBHIgkQUbJlc_mxyNiQU2ce-58txvvavxUuDNtHkwXEx_dzXHwdFwV8oBdTkSC77Y1m9b8rFoq6r6hnnHzlTWjs</recordid><startdate>20120423</startdate><enddate>20120423</enddate><creator>RINGGAARD, LONE MUNCH</creator><creator>MOERK, ARNE</creator><creator>FALDT, ANDRE</creator><creator>HOLM, RENE</creator><creator>ROCK, MICHAEL HAROLD</creator><creator>BRODERSEN, JOERGEN</creator><creator>BANG-ANDERSEN, BENNY</creator><creator>JOERGENSEN, MORTEN</creator><creator>MEALY, MICHAEL J</creator><creator>MOORE, NICHOLAS</creator><creator>LOPEZ DE DIEGO, HEIDI</creator><creator>STENSBOEL, TINE BRYAN</creator><scope>EVB</scope></search><sort><creationdate>20120423</creationdate><title>1-[2-(2,4-Dimetilfenilsulfanil)fenil]piperazina como compuesto con recaptación de serotonina combinada con actividad 5-HT3 y 5-HT1A para el tratamiento del deterioro cognitivo</title><author>RINGGAARD, LONE MUNCH ; MOERK, ARNE ; FALDT, ANDRE ; HOLM, RENE ; ROCK, MICHAEL HAROLD ; BRODERSEN, JOERGEN ; BANG-ANDERSEN, BENNY ; JOERGENSEN, MORTEN ; MEALY, MICHAEL J ; MOORE, NICHOLAS ; LOPEZ DE DIEGO, HEIDI ; STENSBOEL, TINE BRYAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2379200TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>RINGGAARD, LONE MUNCH</creatorcontrib><creatorcontrib>MOERK, ARNE</creatorcontrib><creatorcontrib>FALDT, ANDRE</creatorcontrib><creatorcontrib>HOLM, RENE</creatorcontrib><creatorcontrib>ROCK, MICHAEL HAROLD</creatorcontrib><creatorcontrib>BRODERSEN, JOERGEN</creatorcontrib><creatorcontrib>BANG-ANDERSEN, BENNY</creatorcontrib><creatorcontrib>JOERGENSEN, MORTEN</creatorcontrib><creatorcontrib>MEALY, MICHAEL J</creatorcontrib><creatorcontrib>MOORE, NICHOLAS</creatorcontrib><creatorcontrib>LOPEZ DE DIEGO, HEIDI</creatorcontrib><creatorcontrib>STENSBOEL, TINE BRYAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RINGGAARD, LONE MUNCH</au><au>MOERK, ARNE</au><au>FALDT, ANDRE</au><au>HOLM, RENE</au><au>ROCK, MICHAEL HAROLD</au><au>BRODERSEN, JOERGEN</au><au>BANG-ANDERSEN, BENNY</au><au>JOERGENSEN, MORTEN</au><au>MEALY, MICHAEL J</au><au>MOORE, NICHOLAS</au><au>LOPEZ DE DIEGO, HEIDI</au><au>STENSBOEL, TINE BRYAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>1-[2-(2,4-Dimetilfenilsulfanil)fenil]piperazina como compuesto con recaptación de serotonina combinada con actividad 5-HT3 y 5-HT1A para el tratamiento del deterioro cognitivo</title><date>2012-04-23</date><risdate>2012</risdate><abstract>1-[2-(2,4-Dimetilfenilsulfanil)fenil]piperazina y sus sales farmacéuticamente aceptables, cuyo compuesto es cristalino.
1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on SERT, 5-HT 3 and 5-HT 1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_ES2379200TT3 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 1-[2-(2,4-Dimetilfenilsulfanil)fenil]piperazina como compuesto con recaptación de serotonina combinada con actividad 5-HT3 y 5-HT1A para el tratamiento del deterioro cognitivo |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T13%3A20%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RINGGAARD,%20LONE%20MUNCH&rft.date=2012-04-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2379200TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |